Search Results - "Zamanian, R T"

Insulin resistance in pulmonary arterial hypertension by Zamanian, R. T, Hansmann, G, Snook, S, Lilienfeld, D, Rappaport, K. M, Reaven, G. M, Rabinovitch, M, Doyle, R. L

“…Although obesity, dyslipidemia and insulin resistance (IR) are well known risk factors for systemic cardiovascular disease, their impact on pulmonary arterial…”
Get full text

Drugs and toxins-associated pulmonary arterial hypertension: lessons learned and challenges ahead by de Jesus Perez, V, Kudelko, K, Snook, S, Zamanian, R T

“…Since the identification of the link between pulmonary arterial hypertension (PAH) and exposure to certain drugs and toxins nearly fifty years ago, the…”
Get full text

Kidney dysfunction in patients with pulmonary arterial hypertension by Nickel, N.P., O’Leary, J.M., Brittain, E.L., Fessel, J.P., Zamanian, R.T., West, J.D., Austin, E.D.

“…Pulmonary arterial hypertension (PH) and chronic kidney disease (CKD) both profoundly impact patient outcomes, whether as primary disease states or as…”
Get full text

An Observational Study of Inhaled-Treprostinil Respiratory-Related Safety in Patients with Pulmonary Arterial Hypertension by Zamanian, R. T., Levine, D. J., Bourge, R. C., De Souza, S. A., Rosenzweig, E. B., Alnuaimat, H., Burger, C., Mathai, S. C., Leedom, N., DeAngelis, K., Lim, A., De Marco, T.

“…Inhaled treprostinil (Tyvaso) has been shown to be a safe and effective addition to pulmonary arterial hypertension (PAH) oral therapies; however, the…”
Get full text

C53 CLINICAL EVALUATION AND BIOMARKERS OF PULMONARY HYPERTENSION II: Does Standardizing The Fick Equation Improve The Utility Of The Change In Pvr As A Surrogate For Mortality? by Brunner, N W, Zamanian, R T

Get full text

C52 CLINICAL EVALUATION AND BIOMARKERS OF PULMONARY HYPERTENSION I: Association Between Baseline Pulmonary Vascular Resistance Calculated Using Standardized Oxygen Consumption And Mortality In Pulmonary Arterial Hypertension by Brunner, N W, Zamanian, R T

Get full text

A60 ADVERSE EFFECTS OF TOBACCO, MARIJUANA, AND RECREATIONAL DRUGS: Methamphetamine And Common Pulmonary Diseases: A Retrospective Investigation Of Hospital Discharges In California From 2005 Through 2011 by Tsai, H, Lee, J H, Hedlin, H, Zamanian, R T, Perez, V De Jesus

“…While conditions such as pulmonary arterial hypertension have been associated with its use, METH has not been studied as a potential risk factor for general…”
Get full text

Regulative response of the cranial neural tube after neural fold ablation: spatiotemporal nature of neural crest regeneration and up-regulation of Slug by Sechrist, J, Nieto, M A, Zamanian, R T, Bronner-Fraser, M

“…After unilateral ablation of the avian cranial neural folds, the remaining neuroepithelial cells are able to replace the missing neural crest population…”
Get full text

B20 HOOKED ON PH'OMICS: Whole Exome Sequencing Reveals Ces1 As A Novel Gene In Methamphetamine Induced Pulmonary Arterial Hypertension by Perez, V De Jesus, Orcholski, M, Khurshudyan, A, Yuan, K, Zamanian, R T

Get full text

C106 WRECKING BALL: NEW PARADIGMS IN UNDERSTANDING AND TREATMENT OF PH: Perioperative Morbidity And Mortality In Patients With Pulmonary Hypertension Undergoing Non-Cardiac Surgery: An Analysis Of Admission Records From The Nationwide Inpatient Sample From 2005-2009 by Dudley, K, Lobato, R, Wong, J, Maxwell, B, Rhoads, K, Zamanian, R T

Get full text

D19 CLINICAL STUDIES IN PH: Serial Vasoreactivity Reassessment Is A Prognostic Tool In Pulmonary Arterial Hypertension by Sweatt, A J, Spiekerkoetter, E F, Hsi, A, Sung, Y, Perez, V De Jesus, Kudelko, K, Zamanian, R T

Get full text

B55 REASON TO BELIEVE: CLINICAL PH STUDIES: Using Near-Infrared Spectroscopy To Characterize The Effects Of Inhaled Nitric Oxide On Skeletal Muscle Oxygen Saturation In Adults With Pulmonary Arterial Hypertension by Shaller, B D, Kholdani, C, Hedlin, H, Sweatt, A J, Hsi, A, Spiekerkoetter, E F, Zamanian, R T

Get full text

D53 THE PROMISED LAND: CLINICAL STUDIES IN PULMONARY HYPERTENSION: Evaluation Of Changes In Static And Pulsatile Hemodynamic Indices Across Longitudinal Vasoreactivity Tests In Pah by Sweatt, A J, Spiekerkoetter, E F, Hsi, A, Sung, Y, Jesus Perez, V De, Kudelko, K, Zamanian, R T

Get full text

D53 THE PROMISED LAND: CLINICAL STUDIES IN PULMONARY HYPERTENSION: Dlco Change In Pah Reflects Vascular Function As Determined By Longitudinal Hemodynamic Response To Inhaled Nitric Oxide by Sweatt, A J, Spiekerkoetter, E F, Hsi, A, Sung, Y, Perez, V De Jesus, Kudelko, K, Zamanian, R T

Get full text

D107 DIAMONDS AND PEARLS: PULMONARY HYPERTENSION PHENOTYPES: Discovery Of Proteomic Immune Signatures In Pulmonary Arterial Hypertension By Unsupervised Consensus Clustering by Sweatt, A, Hedlin, H, Balasubramanian, V, Hsi, A, Blum, L, Robinson, W, Nicolls, M R, Rabinovitch, M, Khatri, P, Zamanian, R T

“…Methods Among a PAH cohort treated at Stanford University from 2008-2014 (n=302) and healthy controls (n=97, absence of disease established by questionnaire,…”
Get full text

A67 BREAKDOWN: THE CELLULAR CONTRIBUTION TO PULMONARY HYPERTENSION: Leukotriene B4 Potentiates Bmpr2 Deficiency And Causes Paec Endmt In Pah by Tian, A, Jiang, X, Shuffle, E, Tu, A, Jin, Q, Zamanian, R T, Voelkel, N, Peters-Golden, M, Tuder, R, Rabinovitch, M, Nicolls, M

“…LTB4 directly inhibited BMPR2 signaling in vitro through up-regulation of TGF beta pathway. [...]over-expression of LTB4 in the lung of BMPR2+/- rat carrying a…”
Get full text

D107 DIAMONDS AND PEARLS: PULMONARY HYPERTENSION PHENOTYPES: Clinical Heterogeneity Across Proteomic Immunophenotypes In Pulmonary Arterial Hypertension by Sweatt, A, Hedlin, H, Balasubramanian, V, Hsi, A, Blum, L, Robinson, W, Nicolls, M, Rabinovitch, M, Khatri, P, Zamanian, R T

“…Rationale World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH) arises in the setting of various disease states, genetic mutations, and…”
Get full text

A18 U GOT THE LOOK: DRUGS, TOXINS, GENES AND RISK ASSESSMENT IN PULMONARY HYPERTENSION: Uncovering A Link Between Prescription Amphetamine-Based Stimulants And Pulmonary Hypertension - Data From A Northern California Multi-Specialty, Mixed Payer, Health Care System by Stewart, E M, Rajasingh, C M, Hedlin, H, Romanelli, R J, Wilson, S R, Perez, V De Jesus, Zamanian, R T

“…Using electronic health record data from a large healthcare delivery system in Northern California, we tested the hypothesis that use of PABS is associated…”
Get full text

D107 DIAMONDS AND PEARLS: PULMONARY HYPERTENSION PHENOTYPES: Risk Of Pulmonary Hypertension In Users Of Prescription Amphetamine-Based Stimulants: A Single Center Experience by Stewart, E M, Rajasingh, C M, Hedlin, H, Romanelli, R J, Wilson, S R, Perez, V De Jesus, Zamanian, R T

“…Using electronic health record data from a large healthcare delivery system in Northern California, we tested the hypothesis that use of PABS is associated…”
Get full text

D19 CLINICAL STUDIES IN PH: Comprehensive Characterization Of Insulin Resistance And Its Association With Ventricular Function In Pulmonary Arterial Hypertension by Wells, R E, Cuttica, M, Dash, R, Abbasi, F, De Veerdonk, M Van, Preston, I R, Hemnes, A R, Sweatt, A J, Gomberg-Maitland, M, Zamanian, R T

Get full text